Trial intelligence / Profile preview

TXA for Blood Loss in Hip Fractures

NCT02580227Phase 4Unknown

Sponsor
Good Samaritan Regional Medical Center
Start
Jun 2015
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tranexamic acid, sponsored by Good Samaritan Regional Medical Center. Status: unknown.

02

Drugs

tranexamic acid

Beyond the preview

Go deeper on NCT02580227.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02580227.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call